石田　晋　業績集

英文原著業績（１９９９年から現在まで）

IF (impact factor)：　2022年ISI Journal Citation Reportsより

 

本数

ＩＦ合計

一編あたり

First author

8

121.5

15.2

Corresponding author

37

183.6

5.0

Second author

16

53.0

3.3

その他

338

1017.7

3.0

英文全業績

399

1375.8

3.4

英文著書

  1. Saito W, Ishida S. Acute zonal occult outer retinopathy. Inflammatory and Infectious Ocular Disorders. 2019; 45-50
  2. Kanda A, Ishida S. Roles of the retinal pigment epithelium in neuroprotection. Neuroprotection and Regeneration for Retinal Diseases. 2014; 227-238

英文原著

以下、Corresponding authorの論文の番号に●印を、First authorの論文の番号に＊印を付します。

  1. Mitamura M, Kase S, Suzuki Y, Sakaguchi T, Suimon Y, Sinohara T, Shimizu A, Matsuno Y, Sakai H, Kase M, Ishida S. Diffuse large B-cell lymphoma of the ocular adnexa with flow cytometry analysis and review of the literature. Eur J Ophthalmol. Epub ahead of print
  2. Suimon Y, Kase S, Ito T, Ishida S. A case of giant conjunctival cyst mimicking lymphatic malformation. Eur J Ophthalmol. Epub ahead of print
  3. Suimon Y, Kase S, Kinoshita R, Ishida S. Clinicopathological features of conjunctival MALT lymphomas refractory to radiation therapy. Can J Ophthalmol. in press
  4. Tanaka T, Kase S, Saito M, Hirose I, Murata M, Takakuwa E, Ishida S. Clinicopathological findings in refractory diabetic macular edema-case report. Biomed Rep. in press
  5. Ando R, Hirooka K, Saito M, Kase S, Noda K, Ishida S. Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration. Jpn J Ophthalmol. 2023; 67: 50-58
  6. Arita T, Namba K, Iwata D, Suzuki K, Ogino Y, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. A case of tubulointerstitial nephritis and uveitis syndrome accompanied by subclinical choroiditis. BMC Ophthalmol. 2023; 23:424
  7. Endo H, Kase S, Takahashi M, Ito Y, Sonoda S, Sakoguchi T, Sakamoto T, Katsuta S, Ishida S, Kase M. Changes in choriocapillaris structure occurring in idiopathic macular hole before and after vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2023; 261: 1901-1912.
  8. Igarashi T, Kase S, Suimon Y, Takakuwa E, Ishida S. A case of conjunctival cyst with apocrine hidrocystoma-like features: a clinicopathological study. Int J Ophthalmol. 2023; 16: 465-467
  9. *Ishida S, Chen SJ, Murata T, Ogura Y, Ruamviboonsuk P, Sakamoto T, Fujita T, Kawano M, Ohsawa S, Abreu F, Haskova Z, Ives J, Silverman D, Yoon YH; YOSEMITE and RHINE Investigators. Efficacy, Durability, and Safety of Faricimab in Patients From Asian Countries With Diabetic Macular Edema: 1-Year Subgroup Analysis of the Phase III YOSEMITE and RHINE Trials. Asia Pac J Ophthalmol. 2023; 12: 451-459
  10. Kikuchi K, Tagawa T, Murata M, Ishida S. Effects of Mirogabalin on Hyperalgesia and Chronic Ocular Pain in Tear-Deficient Dry-Eye Rats. Invest Ophthalmol Vis Sci. 2023; 64: 27
  11. Matsumoto K, Kase S, Namba K, Iwata D, Matsuno Y, Ishida S. A case of intraocular metastasis of lung cancer diagnosed using cell block preparation of vitreous humor. Cancer Diagn Progn. 2023; 3: 130-134
  12. Mitamura M, Endo H, Kase S, Dong Z, Takahashi M, Katsuta S, Kase M, Ishida S. Peripapillary circulatory dysfunction precedes structural loss in treatment-naive diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2023; 261: 85-95
  13. Mitamura M, Kase S, Hirooka K, Endo H, Ito Y, Ishida S. Choroidal circulatory and vascular morphological changes in acute macular neuroretinopathy after infection with severe acute respiratory syndrome coronavirus 2: a case report with literature review. In vivo. 2023; 37: 2869-2876
  14. Mitamura M, Kase S, Hirooka K, Ishida S. A case of choroidal melanocytosis observed by multimodal imaging with laser speckle flowgraphy. BMC Ophthalmol. 2023; 23: 180
  15. Mitamura M, Kase S, Hirooka K, Ishida S. Alterations of choroidal circulation and choroidal thickness before and after chemoradiotherapy in a case of metastatic choroidal tumor. BMC Ophthalmol. 2023; 23: 270
  16. Mitamura M, Kase S, Yamashita Y, Hirooka K, Ishida S. Alterations in choroidal circulatory dynamics and choroidal thickness before and after treatment in posterior scleritis. BMC Ophthalmol. 2023; 23: 382
  17. Mitamura M, Noda K, Kase S, Hirooka K, Ishida S. Retinal hypoperfusion detected by wide-field optical coherence tomographic angiography in a case of retinal racemose hemangioma. Retin Cases Brief Rep. 2023; 17: 723-727
  18. Ogino Y, Namba K, Iwata D, Suzuki K, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination. BMC Ophthalmol. 2023; 23: 233
  19. Shinagawa M, Namba K, Mizuuchi K, Iwata D, Hase K, Suzuki K, Hirooka K, Kitaichi N, Hiraoka M, Ishida S. The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt–Koyanagi–Harada Disease.Ocul Immunol Inflamm. 2023; 31: 501-505
  20. Suzuki K, Iwata D, Namba K, Hase K, Hiraoka M, Murata M, Kitaichi N, Foxton R, Ishida S. Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis. PLoS One. 2023; 18: e0294745
  21. Suzuki K, Shinmei Y, Hirooka K, Kanaya R, Shinkai A, Kijima R, Chin S, Ito Y M, Ishida S. Reduction of intraocular pressure and aqueous outflow resistance after modified 360-degree suture trabeculotomy. J Glaucoma. 2023; 32: 204-209
  22. Yamamoto T, Kase S, Shinkai A, Murata M, Kikuchi K, Wu D, Kageyama Y, Shinohara M, Sasase T, Ishida S. Phosphorylation of αB-crystallin involves interleukin-1β-mediated intracellular retention in retinal Müller cells. Invest Ophthalmol Vis Sci. 2023; 64: 20
  23. Hasegawa A, Noda K, Fujiya A, Hirooka K, Anzai T, Ishida S. Outer Retinal Abnormalities in a Patient with Danon Disease. Retin Cases Brief Rep. 2022; 16: 619-621
  24. Fukutsu K, Kase S, Iwata D, Suzuki K, Namba K, Ishida S. The expression of matrix metalloproteinases in eyes with intraocular lymphoma. Ocul Immunol Inflamm. 2022; 30:1798-1802
  25. Fukutsu K, Saito M, Noda K, Murata M, Kase S, Shiba R, Isobai N, Asano Y, Hanawa N, Dohke M, Kase M, Ishida S. Relationship between Brachial-Ankle Pulse Wave Velocity and Fundus Arteriolar Area Calculated Using a Deep-Learning Algorithm. Curr Eye Res. 2022; 47: 1534-1537
  26. Iwata D, Namba K, Yamamoto T, Mizuuchi K, Saito W, Ohno S, Kitaichi N, Ishida S. Recent clinical features of intraocular inflammation in Hokkaido, Japan -comparison with the previous decade. Ocul Immunol Inflamm. 2022; 30: 848-854
  27. Kado R, Kase S, Suimon Y, Ishida S. A case of pleomorphic adenoma of the lacrimal gland invading the lower orbit. Orbit. 2022; 41: 802-804
  28. Kase S, Ishida S. COVID-19-related chronic bilateral dacryoadenitis: a clinicopathological study. JAMA Ophthalmol. 2022; 140: 312-318
  29. Kase S, Namba K, Iwata D, Mizuuchi K, Suzuki K, Ito T, Hase K, Kitaichi N, Ishida S. Diagnostic accuracy of cell block preparations and clinical features affecting it in vitreoretinal lymphoma. J Clin Med. 2022; 11: 1391
  30. Kijima R, Shinmei Y, Chin S, Kanaya R, Shinkai A, Ohguchi T, Nanba K, Ishida S. Long-term Outcomes of Modified 360-degree Suture Trabeculotomy for Uveitic Glaucoma Compared with Primary Open Angle Glaucoma. J Glaucoma. 2022; 31: 682-688
  31. Kijima R, Shinmei Y, Shinkai A, Kanaya R, Chin S, Ishida S. Surgical outcomes of partial ciliary body direct suturing under the scleral flap for traumatic cyclodialysis cleft: A five-case series. Eur J Ophthalmol. 2022; 32: 3712-3719
  32. Mitamura M, Kase S, Hirooka K, Endo H, Ito Y, Cho Y, Ishida S. Alterations of choroidal circulation and vascular morphology in a patient with chronic myeloid leukemia before and after chemotherapy. BMC Ophthalmol. 2022; 22: 160
  33. Noda T, Noda K, Hirooka K, Kase S, Ishida S. Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment. Am J Ophthalmol Case Rep. 2022; 27: 101568
  34. Ota S, Kase S, Tanaka T, Ishida S. A case of conjunctival intraepithelial neoplasia with spheroidal degeneration: a clinicopathological study. Int J Ophthalmol. 2022; 15: 1401-1403
  35. Sone R, Noda K, Hirooka K, Saito M, Ishida S. Insidious progression of atrophic lesions in a case of posterior polar annular choroidal dystrophy. Am J Ophthalmol Case Rep. 2022; 28: 101708
  36. Tanaka T, Kase S, Ishida S. A case of spontaneous avulsion of primary pterygium analyzed with anterior segment optical coherence tomography. Am J Ophthalmol Case Rep. 2022; 26: 101438
  37. Tanimukai T, Noda K, Hirooka K, Kase S, Ishida S. Non-invasive imaging of a vasoproliferative retinal tumor treated with cryopexy. Case Rep Ophthalmol. 2022; 13: 611-616
  38. Mitamura M, Kase S, Suzuki Y, Sakaguchi T, Suimon Y, Dong Y, Hatanaka KC, Sinohara T, Kase M, Ishida S. Follicular lymphoma of the ocular adnexa: clinicopathological findings with flow cytometry analysis of 8 cases. Eur J Ophthalmol. 2022; 32: 1760-1765
  39. Murata M, Noda K, Kase S, Hase K, Wu D, Ando R, Ishida S. Placental growth factor stabilizes VEGF receptor-2 protein in retinal pigment epithelial cells by downregulating glycogen synthase kinase 3 activity. J Biol Chem. 2022; 298: 102378
  40. Fujita Y, Kase S, Ishida S. Molluscum contagiosum of the corneal limbus in an AIDS patient: a clinicopathological case report. BMC Ophthalmol. 2022; 22: 83
  41. Hirooka K, Saito M, Yamashita Y, Hashimoto Y, Terao N, Koizumi H, Noda K, Ishida S. Imbalanced Choroidal Circulation in Eyes with Asymmetric Dilated Vortex Vein. Jpn J Ophthalmol. 2022; 66: 14-18
  42. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. Macrophage-like iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. 2022; 46: 1908-1916
  43. Hirooka K, Saito M, Yamashita Y, Hashimoto Y, Terao N, Koizumi H, Noda K, Ishida S. Imbalanced Choroidal Circulation in Eyes with Asymmetric Dilated Vortex Vein. Jpn J Ophthalmol. 2022; 66: 14-18
  44. Kase S, Endo H, Takahashi M, Yokoi M, Ito Y, Katsuta S, Sonoda S, Sakamoto T, Ishida S, Kase M. Involvements of choroidal vascular structures with local treatments in patients with diabetic macular edema. Eur J Ophthalmol. 2022; 32: 450-459
  45. Kase S, Hasegawa A, Hirooka K, Endo H, Noda K, Ishida S. Laser speckle flowgraphy findings in a patient with radiation retinopathy. Int J Ophthalmol. 2022; 15: 172-174
  46. Shinkai A, Shinmei Y, Takahashi A, Nakamura K, Tagawa Y, Chin S, Ishida S. Cerebrospinal fluid hypovolemia syndrome mimicking ocular myasthenia gravis: A case report. Am J Ophthalmol Case Rep. 2022; 26:101478.
  47. Suimon Y, Kase S, Mitsuhashi T, Ishida S. Undifferentiated pleomorphic sarcoma of the conjunctiva: a case report and review of the literature. Cancer Diagn Progn. 2022; 2: 232-239
  48. Suzuki K, Ishihara M, Nanba K, Ohno S, Goto H, Takase H, Kawano S, Shibuya E, Hase K, Iwata D, Mizuuchi K, Kitaichi N, Mizuki N, Ishida S. Clinical features of ocular sarcoidosis: severe, refrectory, and prolonged inflammation. Jpn J Ophthalmol. 2022; 66: 447-454
  49. Suzuki K, Namba K, Hase K, Mizuuchi K, Iwata D, Ito T, Kitaichi N, Takase H, Ishida S. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet. Am J Ophthalmol Case Rep. 2022; 25: 101363
  50. Suzuki K, Namba K, Kase S, Ogino Y, Hase K, Iwata D, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma. BMC Ophthalmol. 2022; 22: 428
  51. Takahashi K, Iida T, Ishida S, Crawford B, Sakai Y, Mochizuki A, Tsujiuchi R, Tanaka S, Imai K. Effectiveness of Current Treatments for Wet Age-Related Macular Degeneration in Japan: A Systematic Review and Pooled Data Analysis. Clin Ophthalmol. 2022; 16: 531-540
  52. Weng X, Iwata D, Namba K, Suzuki K, Mizuuchi K, Nakamura H, Atsumi T, Ishida S. Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report. Am J Ophthalmol Case Rep. 2022; 25: 101333
  53. Wu D, Kase S, Liu Y, Kanda A, Murata M, Ishida S. Downregulation of AlphaB-crystallin in Retinal Pigment Epithelial Cells Exposed to Diabetes-related Stimuli in Vivoand in Vitro. In Vivo. 2022; 36: 132-139
  54. Yamamoto T, Kase S, Murata M, Ishida S. Serum advanced glycation end-products and alphaB-crystallin in diabetic retinopathy. Biomed Rep. 2022; 4: 28
  55. Yamashita Y, Hashimoto Y, Namba K, Mizuuchi K, Ishida S. Optic nerve head microcirculation in eyes with Vogt-Koyanagi-Harada disease accompanied by anterior ischemic optic neuropathy. Case Rep Ophthalmol. 2022; 12: 899-908
  56. Yamashita Y, Saito M, Hirooka K, Ishida S. Laser speckle flowgraphy findings in focal scleral nodule. Graefes Arch Clin Exp Ophthalmol. 2022; 260: 697-700
  57. Endo H, Kase S, Tanaka H, Takahashi M, Katsuta S, Suzuki Y, Fujii M, Ishida S, Kase M. Factors based on optical coherence tomography correlated with vision impairment in diabetic patients. Sci Rep. 2021; 11: 3004
  58. Fukutsu K, Murata M, Kikuchi K, Yoshida S, Noda K, Ishida S. ROCK1 mediates retinal glial cell migration promoted by acrolein. Front Med. 2021; 8: 717602
  59. Fukutsu K, Saito M, Noda K, Murata M, Kase S, Shiba R, Isogai N, Asano Y, Hanawa N, Dohke M, Kase M, Ishida S. A deep learning architecture for vascular area measurement in fundus images. Ophthalmology Science. 2021; 1: 100004
  60. Hase K, Kase S, Kanda A, Shinmei Y, Noda K, Ishida S. Expression of vascular endothelial growth factor-C in the trabecular meshwork of patients with neovascular glaucoma and primary open-angle glaucoma. J Clin Med. 2021; 10: 2977
  61. Hashimoto Y, Saito W, Kanaizumi S, Saito M, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with acute zonal occult outer retinopathy according to anti-retinal antibody status. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 2967-2976
  62. Hirakata T, Fujinami K, Saito W, Kanda A, Hirakata A, Ishida S, Murakami A, Tsunoda K, Miyake Y. Acute Unilateral Inner Retinal Dysfunction with Photophobia - Importance of Electrodiagnosis -. Jpn J Ophthalmol. 2021; 65: 42-53
  63. Hosaka F, Saito W, Kase S, Ishida S. Gliotic opaque posterior hyaloid membrane separation: report of two cases. BMC Ophthalmol. 2021; 21: 308
  64. Kanaya R, Kijima R, Shinmei Y, Shinkai A, Ohguchi T, Namba K, Chin S, Ishida S. Surgical Outcomes of Trabeculectomy in Uveitic Glaucoma: A Long-Term, Single-Center, Retrospective Case-Control Study. J Ophthalmol. 2021; 2021: 5550776
  65. Kase S, Endo H, Takahashi M, Yokoi M, Ito Y, Saito M, Ishida S, Kase M. Choroidal vascular structures in diabetic patients: A meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 3537-3548
  66. Kase S, Namba K, Iwata D, Mizuuchi K, Ito T, Hase K, Suzuki K, Onozawa M, Kitaichi N, Ishida S. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study. Cancer Diagnosis & Prognosis. 2021; 1: 69-75
  67. Kase S, Noda K, Ishida S. Histological observation in pachyvessels in a patient with choroidal melanoma. Int J Ophthalmol. 2021; 14: 777-779
  68. Mitamura M, Kase S, Ohguchi T, Ishida S. A case of pterygium-like proliferation containing postoperative limbal dermoid remnants: a clinicopathological study. BMC Ophthalmol. 2021; 21: 12
  69. Saito W, Hashimoto Y, Hirooka K, Ishida S. Choroidal thickness changes in a patient diagnosed with central serous chorioretinopathy during follow-up for pachychoroid pigment epitheliopathy. Retin Cases Brief Rep. 2021; 15: 10-14
  70. Shinkai A, Saito W, Hashimoto Y, Saito M, Kase S, Noda K, Ishida S. Morphological features of macular telangiectasia type 2 in Japanese patients. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 1179-1189
  71. Shinkai A, Shinmei Y, Hirooka K, Tagawa Y, Nakamura K, Chin S, Ishida S. Optical coherence tomography as a possible tool to monitor and predict disease progression in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Mitochondrion. 2021; 56: 47-51
  72. Suimon Y, Kase S, Shimoyama S, Ishida S. A case of IgG4-related ophthalmic disease with coronary arteritis. Ophthal Plast Reconstr Surg. 2021; 37: e43-e45
  73. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 971-978
  74. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Validation of systemic parameters for the diagnosis of ocular sarcoidosis. Jpn J Ophthalmol. 2021; 65: 191-198
  75. Yamamoto T, Kanda A, Kase S, Ishida S. Hypoxia induces galectin-1 expression via autoinduction of placental growth factor in retinal pigment epithelium cells. Invest Ophthalmol Vis Sci. 2021; 62: 22
  76. Endo H, Kase S, Saito M, Yokoi M, Takahashi M, Ishida S, Kase M. Choroidal thickness in diabetic patients without diabetic retinopathy: a meta-analysis. Am J Ophthalmol. 2020; 218: 68-77
  77. Endo H, Kase S, Takahashi M, Saito M, Yokoi M, Sugawara C, Katsuta S, Ishida S, Kase M. Relationship between diabetic macular edema and choroidal layer thickness. PLoS One. 2020; 15: e0226630
  78. Fukutsu K, Namba K, Iwata D, Mizuuchi K, Kase S, Suzuki K, Shimizu H, Shibata Y, Yamawaki F, Onozawa M, Ishida S. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging. BMC Ophthalmol. 2020; 20: 94
  79. Hasegawa Y, Hashimoto Y, Shinmei Y, Ishida S. Optic nerve head microcirculation in congenital nasal optic disc hypoplasia. Graefes Arch Clin Exp Ophthalmol. 2020; 258: 211-213
  80. Ishizuka ET, Kanda A, Shinmei Y, Ohguchi T, Tagawa Y, Hase K, Yamamoto T, Noda K, Chin S, Ishida S. Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma. J Clin Med. 2020; 9: E2336
  81. Kanda A, Hirose I, Noda K, Murata M, Ishida S.Glucocorticoid-transactivated TSC22D3 attenuates hypoxia- and diabetes-induced Müller glial galectin-1 expression via HIF-1α destabilization. J Cell Mol Med. 2020; 24: 4589-4599
  82. Kase S, Chin S, Hamanaka T, Shinmei Y, Ohguchi T, Ishida S. Histological observation of trabecular meshwork in a patient with Axenfeld-Rieger syndrome -A new theory for the mechanism of ectropion uvea in congenital glaucoma-. Int J Ophthalmol. 2020; 13: 1167-1169
  83. Kase S, Endo H, Takahashi M, Saito M, Yokoi M, Ito Y, Katsuta S, Sonoda S, Sakamoto T, Ishida S, Kase M. Alteration of choroidal vascular structure in diabetic retinopathy. Br J Ophthalmol. 2020; 104: 417-421
  84. Kase S, Endo H, Takahashi M, Ito Y, Saito M, Yokoi M, Katsuta S, Sonoda S, Sakamoto T, Ishida S, Kase M. Alteration of choroidal vascular structure in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2020; 258: 971-977
  85. Kase S, Namba K, Kanno-Okada H, Onozawa M, Hidaka D, Iwata D, Mizuuchi K, Fukuhara T, Fukuhara J, Kitaichi N, Matsuno Y, Ishida S. Immunohistochemical and immunocytochemical analyses in patients with vitreoretinal lymphoma. Ocul Immunol Inflamm. 2020; 28: 147–155
  86. Kataoka K, Kase S, Noda K, Ishida S. Laser speckle flowgraphy findings in a patient with choroidal macrovessel. Ophthalmol Retina. 2020; 4: 1123-1124
  87. Kikuchi K, Dong Z, Shinmei Y, Murata M, Kanda A, Noda K, Harada T, Ishida S. Cytoprotective effect of astaxanthin in a model of normal intraocular pressure glaucoma. J Ophthalmol. 2020; 2020: 9539681
  88. Kikuchi K, Murata M, Noda K, Kase S, Tagawa Y, Kageyama Y, Shinohara M, Sasase T, Ishida S. Diabetic Cataract in Spontaneously Diabetic Torii Fatty Rats. J Diabetes Res. 2020; 2020: 3058547
  89. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, Ishida S. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354. Biochem Biophys Res Commun. 2020; 525: 589-594
  90. Liu Y, Noda K, Murata M, Wu D, Kanda A, Ishida S. Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice. J Clin Med. 2020; 9: E2242
  91. Mitamura M, Kase S, Hirooka K, Ishida S. Laser speckle flowgraphy in juxtapapillary retinal capillary hemangioblastoma: a case report on natural course and therapeutic effect. Oncotarget. 2020; 11: 3800-3804
  92. Mitamura M, Kase S, Ishida S. Multimodal imaging in sclerochoroidal calcification: a case report and literature review. BMC Ophthalmol. 2020; 20: 248
  93. Mitamura M, Kase S, Sakaguchi T, Suzuki Y, Suimon Y, Dong Y, Hatanaka CK, Shinohara T, Kase M, Ishida S. Solitary fibrous tumor of the orbit: A clinicopathologic study of two cases with review of the literature. In Vivo. 2020; 34: 3649-3654
  94. Mitamura M, Kase S, Suimon Y, Ito T, Ishida S. A case of metastatic iris tumor observed with anterior segment optical coherence tomography before and after radiation therapy. In Vivo. 2020; 34: 2159-2162
  95. Miura G, Baba T, Iwase T, Ohde H, Kanda A, Saito W, Ishida S, Yamamoto S. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report. BMC Ophthalmol. 2020; 20: 132
  96. Mizuuchi K, Saito W, Namba K, Ishida S. Multiple evanescent white dot syndrome and panuveitis: a case report. J Ophthalmic Inflamm Infect. 2020; 10: 26
  97. Murata M, Noda K, Ishida S. Pathological role of unsaturated aldehyde acrolein in diabetic retinopathy. Front Immunol. 2020; 11: 589531
  98. Saito M, Noda K, Saito W, Hirooka K, Hashimoto Y, Ishida S. Increased choroidal blood flow and choroidal thickness in patients with hypertensive chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2020; 258: 233-240
  99. Saito W, Hashimoto Y, Hirooka K, Ishida S. Changes in choroidal blood flow velocity in patients diagnosed with central serous chorioretinopathy during follow-up for pachychoroid pigment epitheliopathy. Am J Ophthalmol Case Rep. 2020; 18: 100651
  100. Shinmei Y, Takahashi A, Nakamura K, Shinkai A, Tagawa Y, Chin S, Ishida S. Cerebrospinal fluid hypovolemia syndrome after a traffic accident with abnormal eye movements: A case report. Am J Ophthalmol Case Rep. 2020; 20: 100997
  101. Suimon Y, Kase S, Miura I, Ishijima K, Ishida S. Alteration of cell surface markers CD38 and CD138 in lymphoproliferative disorders in the ocular adnexa. Anticancer Res. 2020; 40: 2019-2023
  102. Wu D, Kanda A, Liu Y, Noda K, Murata M, Ishida S. Involvement of Müller glial autoinduction of transforming growth factor-β in diabetic fibrovascular proliferation via glial-mesenchymal transition. Invest Ophthalmol Vis Sci. 2020; 61: 29
  103. Wu D, Noda K, Murata M, Liu Y, Kanda A, Ishida S. Regulation of Spermine Oxidase through Hypoxia-inducible Factor-1α Signaling in Retinal Glial Cells under Hypoxic Conditions. Invest Ophthalmol Vis Sci. 2020; 61: 52
  104. Endo H, Kase S, Ito Y, Takahashi M, Yokoi M, Katsuta S, Sonoda S, Sakamoto T, Ishida S, Kase M. Relationship between choroidal structure and duration of diabetes. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 1133-1140
  105. Hase K, Kanda A, Noda K, Ishida S. Increased plasma galectin-1 correlates with advanced glycation end products and interleukin-1β in patients with proliferative diabetic retinopathy. Int J Ophthalmol. 2019; 12: 692-694
  106. Hashimoto Y, Saito W, Hasegawa Y, Noda K, Ishida S. Involvement of inner choroidal layer in choroidal thinning during regression of multiple evanescent white dot syndrome. J Ophthalmol. 2019; 6816925
  107. Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 1751-1758
  108. Hashimoto Y, Saito W, Saito M, Hasegawa Y, Ishida S. Increased thickness and decreased blood flow velocity of the choroid in a patient with acute macular neuroretinopathy. BMC Ophthalmol. 2019; 19: 109
  109. Hirose I, Kanda A, Noda K, Ishida S. Glucocorticoid receptor inhibits Müller glial galectin-1 expression via DUSP1-dependent and -independent deactivation of AP-1 signalling. J Cell Mol Med. 2019; 23: 6785-6796
  110. Ishijima K, Shinmei Y, Nozaki M, Yamaguchi S, Chin S, Ishida S. Sudden bilateral vision loss due to third ventricular cavernous angioma with intratumoral hemorrhage - case report. BMC Ophthalmol. 2019; 19: 259
  111. Kanaya R, Kase S, Ishijima K, Ishida S. Usefulness of topical interferon alpha-2b eye drop as an adjunctive therapy following surgical resection in ocular surface squamous neoplasia. In Vivo. 2019; 33: 2211-2215
  112. ●Kanda A, Ishida S. (Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy. J Diabetes Investig. 2019; 10: 6-17
  113. ●Kanda A, Noda K, Hirose I, Ishida S. TGF-β-SNAIL axis induces Müller glial-mesenchymal transition in the pathogenesis of idiopathic epiretinal membrane. Sci Rep. 2019; 9: 673
  114. Kase S, Ishida S. Adenosquamous carcinoma arising in bulbar conjunctiva. Ophthal Plast Recontr Surg. 2019; 35: e109-e110
  115. Kase S, Ishida S. Photocoagulation for juxtapapillary retinal hemangioma in a young girl: A case report. Mol Clin Oncol. 2019; 10: 521-523
  116. Kijima R, Sasaki O, Shinmei Y, Ohguchi T, Takeda A, Chin S, Ishida S. Changes in intraocular pressure in single ventricle patients after the Glenn or Fontan procedure. J Glaucoma. 2019; 28: 1012-1014
  117. Kikuchi I, Kase S, Hashimoto Y, Hirooka K, Ishida S. Involvement of circulatory disturbance in optic disk melanocytoma with visual dysfunction. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 835-841
  118. Liu Y, Kanda A, Wu D, Ishizuka ET, Kase S, Noda K, Ichihara A, Ishida S. Suppression of choroidal neovascularization and fibrosis by a novel RNAi therapeutic agent against (pro)renin receptor. Mol Ther Nucleic Acids.2019; 17: 113-125
  119. Murata M, Noda K, Yoshida S, Saito M, Fujiya A, Kanda A, Ishida S. Unsaturated aldehyde acrolein promotes retinal glial cell migration. Invest Ophthalmol Vis Sci. 2019; 60: 4425-4435
  120. Shibata Y, Kase S, Namba K, Ishida S. A case of nodular posterior scleritis simulating intraocular tumor. Int J Ophthalmol. 2019; 12: 685-688
  121. Shinkai A, Saito W, Hashimoto Y, Ishida S. Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis. BMC Ophthalmol. 2019; 19: 267
  122. Suimon Y, Kase S, Ishijima K, Kanno-Okada H, Ishida S. Clinicopathological features of cystic lesions in the eyelid. Biomed Rep. 2019; 10: 92-96
  123. Tagawa Y, Noda K, Ohguchi T, Tagawa Y, Ishida S, Kitaichi N. Corneal hyperalgesia in patients with short tear film break-up time dry eye. Ocul Surf. 2019; 17: 55-59
  124. Uraki T, Namba K, Mizuuchi K, Iwata D, Ohno S, Kitaichi N, Ishida S. Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis. Am J Ophthalmol Case Rep. 2019; 14: 87-91
  125. Wu D, Kanda A, Liu Y, Kase S, Noda K, Ishida S. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition. FASEB J. 2019; 33: 2498-2513
  126. Ando R, Saito W, Kanda A, Kase S, Fujinami K, Sugahara M, Nakamura Y, Eguchi S, Mori S, Noda K, Shinoda K, Ishida S.Clinical features of Japanese patients with anti-α-enolase antibody-positive autoimmune retinopathy: Novel subtype of multiple drusen. Am J Ophthalmol. 2018; 196: 181-196
  127. Fukutsu K, Kase S, Ishijima K, Kinoshita R, Ishida S. The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma. Radiat Oncol. 2018; 13: 95
  128. Horie Y, Yamamoto T, Yamamoto T, Amenomori H, Yokoyama C, Shinagawa M, Maruyama T, Nakamine N, Oguma Y, Satoh I, Tsutsumi M, Terumitsu M, Ohno S, Ishida S, Kitaichi N, Cataract Surgery under Conventional Sedation with Dexmedetomidine:Efficacy and Safety in Patients with Psychiatric or NeurologicalConditions. J Anesth Clin Res. 2018; 9: 846.
  129. Kase S, Kikuchi I, Ishida S. Expression of VEGF in human conjunctival melanoma analyzed with immunohistochemistry. Clin Ophthalmol. 2018; 12: 2363-2367
  130. Kase S, Mori S, Noda K, Ishida S. Anterior proliferative vitreoretinopathy in a patient with Coats disease. Int J Ophthalmol. 2018; 11: 343-345
  131. Kase S, Suimon Y, Ishijima K, Ishida S. Rhegmatogenous retinal detachment in a patient with choroidal melanoma simulating choroidal detachment. J Med Case Rep. 2018; 12: 389
  132. Ohtani M, Horie Y, Tagawa Y, Ishida S, Kitaichi N. Patients preference of diquafosol or rebamipide eye drops for the treatment of mild dry eye - a pilot study. Curr Trend Ophthalmol. 2018; 1: 39-45
  133. Saito M, Noda K, Saito W, Ishida S. Relationship between choroidal blood flow velocity and choroidal thickness in patients with regression of acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2018; 256: 227-229
  134. Sakai M, Takase H, Namba K, Mizuuchi K, Iwata D, Ishida S. Two cases of cytomegalovirus panuveitis in immunocompetent patients. Am J Ophthalmol Case Rep. 2018; 10: 189-191
  135. Suimon Y, Kase S, Ishijima K, Kanno-Okada H, Ishida S. A clinicopathological study on IgG4-related ophthalmic disease. Int J Ophthalmol. 2018; 11: 1539-1544
  136. Takita A, Hashimoto Y, Saito W, Kase S, Ishida S. Changes in blood flow velocity and thickness of the choroid in a patient with leukemic retinopathy. Am J Ophthalmol Case Rep. 2018; 12: 68-72
  137. Tanaka A, Saito W, Kase S, Ishijima K, Noda K, Ishida S. Role of the epipapillary membrane in maculopathy associated with cavitary optic disc anomalies: morphology, surgical outcomes, and histopathology. J Ophthalmol. 2018; 5680503
  138. Yoshida S, Murata M, Noda K, Matsuda T, Saito M, Saito W, Kanda A, Ishida S. Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells. Jpn J Ophthalmol. 2018; 62: 256-264
  139. Dong Y, Kanda A, Noda K, Saito W, Ishida S. Pathologic roles of receptor-associated prorenin system in idiopathic epiretinal membrane. Sci Rep. 2017; 7: 44266
  140. Dong Y, Noda K, Murata M, Yoshida S, Saito W, Kanda A, Ishida S. Localization of acrolein-lysine adduct in fibrovascular tissues of proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 111-117
  141. Hase K, Kanda A, Hirose I, Noda K, Ishida S. Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy. PLoS ONE. 2017; 12: e0189696
  142. Hashimoto Y, Saito W, Saito M, Hasegawa Y, Takita A, Mori S, Noda K, Ishida S. Relationship between choroidal thickness and visual field impairment in acute zonal occult outer retinopathy. J Ophthalmol. 2017; 2017:2371032
  143. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids. PLoS One. 2017; 12: e0172612
  144. Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the east along the Silk Road: a literature survey. Ocul Immunol Inflamm. 2017; 25: 37-40
  145. Ishiguro Y, Homma S, Yoshida T, Ohno Y, Ichikawa N, Kawamura H, Hata H, Kase S, Ishida S, Okada-Kannno H, Hatanaka K, Taketomi A. Usefulness of PET/CT for early detection of internal malignancies in patients with Muir–Torre syndrome: report of two cases. Surg Case Rep. 2017; 3: 71
  146. Ishikawa Y, Hashimoto Y, Saito W, Ando R, Ishida S. Blood flow velocity and thickness of the choroid in a patient with chorioretinopathy associated with ocular blunt trauma. BMC Ophthalmol. 2017; 17: 8
  147. Iwata D, Mizuuchi K, Aoki K, Horie Y, Kase S, Namba K, Ohno S, Ishida S, Kitaichi N. Serial observation and clinical features of uveitis in Hokkaido, Japan. Ocul Immunol Inflamm. 2017; 25: S15-18
  148. ●Kanda A, Dong Y, Noda K, Saito W, Ishida S. Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy. Sci Rep. 2017; 7: 16168
  149. ●Kanda A, Ishizuka ET, Shibata A, Matsumoto T, Toyofuku H, Noda K, Namba K, Ishida S. A novel single-strand RNAi therapeutic agent targeting (pro)renin receptor suppresses ocular inflammation. Mol Ther Nucleic Acids. 2017; 7: 116-126
  150. Kase S, Chin S, Hamanaka T, Shinmei Y, Ohguchi T, Kijima R, Matsuda A, Ishida S. Histological findings in the trabecular meshwork of a patient with atopic glaucoma. Open Ophthalmol J. 2017; 11: 103-106
  151. Kase S, Ishijima K, Uraki T, Suimon Y, Suzuki Y, Kase M, Ishida S. Usefulness of flow cytometry in diagnosis of IgG4-related ophthalmic disease and extranodal marginal zone B-cell lymphoma of the ocular adnexa. Anticancer Res. 2017; 37: 5001-5004
  152. Kase S, Ohguchi T, Ishida S. Catastrophic thermal corneoscleral injury treated with transplantation of donor scleral graft. Case Rep Ophthalmol. 2017; 8: 349-352
  153. Kase S, Shinohara T, Kase M, Ishida S. Effect of topical rebamipide on goblet cells in the lid wiper of human conjunctiva. Exp Ther Med. 2017; 13: 3516-3522
  154. Kase S, Shinohara T, Noda M, Ishida S, Kase M. Vascular anomaly in the levator aponeurosis of neurofibromatosis type 1. Int J Ophthalmol. 2017；10：656-657
  155. Kikuchi I, Kase S, Ishijima K, Ishida S. Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection. Graefes Arch Clin Exp Ophthalmol. 2017; 255: 2271-2276
  156. Kinoshita S, Ohguchi T, Noda K, Murata M, Yasueda S, Obata H, Matsunaga T, Fukushima T, Kanda A, Ishida S. Evaluation of the safety and tolerability of conjunctival ring for posterior segment of the eye. Curr Eye Res. 2017; 30: 1-6
  157. Matsuda T, Noda K, Murata M, Kawasaki A, Kanda A, Mashima Y, Ishida S.  Vascular adhesion protein-1 blockade suppresses ocular inflammation afterretinal laser photocoagulation in mice. Invest Ophthalmol Vis Sci. 2017； 58：3254-3261
  158. Murata M, Noda K, Kawasaki A, Yoshida S, Dong Y, Saito M, Dong Z, Ando R, Mori S, Saito W, Kanda A, Ishida S. Soluble vascular adhesion protein-1 mediates spermine oxidation as semicarbazide-sensitive amine oxidase: possible role in proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 1674-1683
  159. Ogura Y, Shiraga F, Terasaki H, Ohji M, Ishida S, Sakamoto T, Hirakata A, Ishibashi T. Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists. Jpn J Ophthalmol. 2017; 61: 43-50
  160. Suimon Y, Saito W, Hirooka K, Kanda A, Kitai H, Sakakibara-Konishi J, Ishida S. Improvements of visual function and outer retinal morphology following spontaneous regression of cancer in anti-recoverin cancer-associated retinopathy. Am J Ophthalmol Case Rep. 2017; 5: 137-140
  161. Tagawa Y, Namba K, Nakazono Y, Iwata D, Ishida S. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis. Allergol Int. 2017; 66: 338-343
  162. Dong Y, Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Inafuku S, Tagawa Y, Ishizuka ET, Saito W, Murata M, Kanda A, Noda K, Ishida S. Phosphorylation of alphaB-crystallin in epiretinal membrane of human proliferative diabetic retinopathy. Int J Ophthalmol. 2016; 9: 1100-1105
  163. Dong Y, Kase S, Dong Z, Fukuhara J, Tagawa Y, Ishizuka ET, Murata M, Shinmei Y, Ohguchi T, Kanda A, Noda K, Ishida S. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium. Int J Mol Med. 2016; 38: 545-550
  164. Dong Z, Shinmei Y, Dong Y, Inafuku S, Fukuhara J, Ando R, Kitaichi N, Kanda A, Tanaka K, Noda K, Harada T, Chin S, Ishida S. Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma. Heliyon. 2016; 2: e00191
  165. Hashimoto Y, Saito W, Saito M, Hasegawa Y, Mori S, Noda K, Ishida S. Relationship between choroidal thickness and visual impairment in multiple evanescent white dot syndrome. Acta Ophthalmol. 2016; 94: e804-e806
  166. Hirooka K, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Ishida S. Increased choroidal blood flow velocity with regression of acute posterior multifocal placoid pigment epitheliopathy. Jpn J Ophthalmol.2016; 60: 172-178
  167. Horie Y, Kitaichi N, Hijioka K, Sonoda K, Saishin Y, Kezuka T, Goto H, Takeuchi M, Nakamura S, Kimoto T, Shimakawa M, Kita M, Sugita S, Mochizuki M, Hori J, Iwata M, Shoji J, Fukuda M, Kaburaki T, Numaga J, Kawashima H, Fukushima A, Joko T, Takai N, Ozawa Y, Meguro A, Mizuki N, Namba K, Ishida S, Ohno S. Ocular Behçet’s disease is less complicated with allergic disorders. A nationwide survey in Japan. Clin Exp Rheumatol. 2016; 102: 1100-1105
  168. Inafuku S, Noda K, Amano M, Nishimura S, Ishida S. Increase of sialylated N-glycans in eyes with neovascular glaucoma secondary to proliferative diabetic retinopathy. Curr Eye Res. 2016; 15: 721-724
  169. Kanda A, Ishida S. Receptor-associated prorenin system contributes to development of inflammation and angiogenesis in proliferative diabetic retinopathy. Inflamm Regen. 2016; 36: 22
  170. Kase S, Namba K, Iwata D, Mizuuchi K, Kitaichi N, Tagawa Y, Okada-Kanno H, Matsuno Y, Ishida S. Diagnostic efficacy of cell block method for vitreoretinal lymphoma. Diagn Pathol. 2016; 11: 29
  171. Kase S, Saito W, Mori S, Saito M, Ando R, Dong Z, Suzuki T, Noda K, Ishida S. Clinical and histological evaluation of large macular holes surgery using the inverted internal limiting membrane flap technique. Clin Ophthalmol. 2016; 11: 9–14
  172. Kinoshita S, Noda K, Saito W, Kanda A, Ishida S. Vitreous levels of vascular endothelial growth factor-B in proliferative diabetic retinopathy. Acta Ophthalmol. 2016; 94: e521-523
  173. Saito W, Saito M, Hashimoto Y, Ishida S. Occult hypertensive choroidopathy: novel finding of suprachoroidal fluid. Graefes Arch Clin Exp Ophthalmol. 2016; 254:1229-1231
  174. Sakurai Y, Namba K, Mizuuchi K, Nomura T, Ishida S. A case of severe panuveitis associated with psoriasis vulgaris successfully treated with infliximab. Case Report Ophthalmol. 2016; 7:191-194
  175. Satoh M, Namba K, Kitaichi N, Endo N, Kitamei H, Iwata D, Ohno S, Ishida S, Onoe K, Watarai H, Taniguchi M, Ishibashi T, Stein-Streilein J, Sonoda K, Kaer L V, Iwabuchi K. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. Exp Eye Res. 2016; 153: 79-89
  176. Shinmei Y, Kijima R, Nitta T, Ishijima K, Ohguchi T, Chin S, Ishida S. Modified 360-degree suture trabeculotomy combined with phacoemulsification and intraocular lens implantation for glaucoma and coexisting cataract. J Cataract Refract Surg. 2016; 42: 1634-1641
  177. Shinmei Y, Nitta T, Saito H, Ohguchi T, Kijima R, Chin S, Ishida S. Continuous intraocular pressure monitoring during nocturnal sleep in patients with obstructive sleep apnea syndrome. Invest Ophthalmol Vis Sci. 2016; 57: 2824-2830
  178. Tagawa Y, Namba K, Mizuuchi K, Takemoto Y, Iwata D, Uno T, Fukuhara T, Hirooka K, Kitaichi N, Ohno S, Ishida S. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2016; 100: 473-477
  179. Takemoto Y, Namba K, Uno T, Mizuuchi K, Iwata D, Ohno S, Hirooka K, Hashimoto Y, Saito W, Sugiyama K, Ishida S. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy. Acta Ophthalmol. 2016; 94: e629-e636
  180. Fujiya A, Noda K, Yoshida S, Saito W, Ishida S. Increased vascular endothelial growth factor level in the subretinal fluid of eye with vasoproliferative retinal tumors. Retin Cases Brief Rep. 2015; 9: 154-156
  181. Hase K, Namba K, Saito W, Ohno S, Ishida S. A case of tuberculous endophthalmitis successfully treated with vitrectomy followed by antituberculous agents. J Ophthalmic Inflamm Infect. 2015; 5: 14
  182. Hashimoto Y, Saito W, Fujiya A, Yoshizawa C, Hirooka K, Mori S, Noda K, Ishida S. Changes in inner and outer retinal layer thicknesses after vitrectomy for idiopathic macular hole: Implications for visual prognosis. PLoS One. 2015; 10: e0135925
  183. Hashimoto Y, Saito W, Saito M, Hirooka K, Mori S, Noda K, Ishida S. Decreased choroidal blood flow velocity in the pathogenesis of multiple evanescent white dot syndrome. Graefes Arch Clin Exp Ophthalmol. 2015; 253: 1457-1464
  184. Hashimoto Y, Saito W, Saito M, Hirooka K, Mori S, Noda K, Ishida S. Increased choroidal blood flow velocity with regression of unilateral acute idiopathic maculopathy. Jpn J Ophthalmol. 2015; 59: 252-260
  185. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids. BMC Ophthalmol. 2015; 15: 181
  186. Hirooka K, Saito W, Namba K, Takemoto Y, Mizuuchi K, Uno T, Tagawa Y, Hashimoto Y, Ishida S. Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015; 253: 609-617
  187. Inafuku S, Noda K, Amano M, Ohashi T, Yoshizawa C, Saito W, Kanda A, Nishimura S, Ishida S. Alteration of N-glycan profiles in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015; 56: 5316-5322
  188. ●Kanda A, Noda K, Ishida S. ATP6AP2/(pro)renin receptor contributes to glucose metabolism via stabilizing the pyruvate dehydrogenase E1 ß subunit. J Biol Chem. 2015; 290:9690-9700
  189. ●Kanda A, Noda K, Saito W, Ishida S. Aflibercept traps galectin-1, an angiogenic factor associated with diabetic retinopathy. Sci Rep. 2015; 5: 17946
  190. Kase S, Yokoi M, Ishida S, Kase M. Measurement of interleukins in vitreous infusion fluid. Biomed Rep. 2015; 3: 818-820
  191. Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, Takeno M, Ishigatsubo Y, Mizuki N, Nasonov E, Ishida S, Ohno S. Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol. 2015; 34: 321-327
  192. Mizoguchi A, Hashimoto Y, Shinmei Y, Nozaki M, Ishijima K, TagawaY, Ishida S. Macular thickness changes in a patient with Leber’s hereditary optic neuropathy. BMC Ophthalmol. 2015; 15: 27
  193. Morooka S, Hoshina M, Kii I, Okabe T, Kojima H, Inoue N, Okuno Y, Denawa M, Yoshida S, Fukuhara J, Ninomiya K, Ikura T, Furuya T, Nagano T, Noda K, Ishida S, Hosoya T, Ito N, Yoshimura N, Hagiwara M. Identification of a dual Inhibitor of SRPK1 and CK2 that attenuates pathological angiogenesis of macular degeneration in mice. Mol Pharmacol. 2015; 88: 316-325
  194. Saito M, Saito W, Hirooka K, Hashimoto Y, Mori S, Noda K, Ishida S. Pulse waveform changes in macular choroidal hemodynamics with regression of acute central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2015; 56: 6515-6522
  195. Saito S, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Namba K, Ishida S. Acute zonal occult outer retinopathy in Japanese patients: Clinical features, visual function, and factors affecting visual function. PLoS One. 2015；10：e0125133
  196. Tagawa Y, Namba K, Ogasawara R, Kanno H, Ishida S. A case of mature natural killer-cell neoplasm manifesting multiple choroidal lesions – Primary intraocular NK-cell lymphoma. Case Rep Ophthalmol. 2015；21：380-384
  197. Takahashi A, Saito W, Hashimoto Y, Ishida S. Multiple evanescent white dot syndrome associated with retinal vasculitis. Int Med Case Rep J. 2015; 8: 209-213
  198. Ando R, Noda K, Tomaru U, Kamoshita M, Ozawa Y, Notomi S, Hisatomi T, Noda M, Kanda A, Ishibashi T, Kasahara M, Ishida S. Decreased proteasomal activity causes photoreceptor degeneration in mice. Invest Ophthalmol Vis Sci. 2014; 55: 4682-4690
  199. Ando R, Noda K, Namba S, Saito W, Kanda A, Ishida S. Aqueous humor levels of placental growth factor in diabetic retinopathy. Acta Ophthalmol. 2014; 92: 245-6
  200. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. Epub 2014; 96: 1077-1085
  201. Gonzalez G, Koyanagi KO, Aoki K, Kitaichi N, Ohno S, Kaneko H, Ishida S, Watanabe H. Intertypic modular exchanges of genomic segments by homologous recombination at universally conserved segments in human adenovirus species D. Gene. 2014; 547: 10-17
  202. Hashimoto Y, Saito W, Noda K, Ishida S. Acquired focal choroidal excavation associated with multiple evanescent white dot syndrome: observations at onset and a pathogenic hypothesis. BMC Ophthalmol. 2014; 14:135
  203. Hashimoto Y, Saito W, Saito M, Hirooka K, Fujiya A, Yoshizawa C, Noda K, Ishida S. Retinal outer layer thickness increases after vitrectomy for epiretinal membrane and visual improvement positively correlates with photoreceptor outer segment length. Graefes Arch Clin Exp Ophthalmol. 2014; 252: 219-226
  204. Hashimoto Y, Saito W, Saito M, Hirooka K, Yoshizawa C, Noda K, Ishida S. Retinal outer layer thickness increases with regression of multiple evanescent white dot syndrome and visual improvement positively correlates with photoreceptor outer segment length. Acta Ophthalmol. 2014; 92: 591-592
  205. Hiraoka M, Abe A, Lennikov A, Kitaichi N, Ishida S, Ohguro H. Increase of lysosomal phospholipase A2 in aqueous humor by uveitis. Exp Eye Res. 2014; 118: 13-19
  206. Hirooka K, Saito W, Hashimoto Y, Saito M, Ishida S. Increased macular choroidal blood flow velocity and decreased choroidal thickness with regression of punctate inner choroidopathy. BMC Ophthalmol. 2014; 14: 73
  207. Hirooka K, Saito W, Noda K, Ishida S. Enhanced-depth imaging optical coherence tomography and laser speckle flowgraphy in a patient with acute macular neuroretinopathy. Ocul Immunol Inflamm. 2014; 22: 485-489
  208. Inafuku S, Noda K, Amano M, Ohashi, Yoshizawa C, Saito W, Kanda A, Nishimura S, Ishida S. A comparison of N-glycan profiles in human plasma and vitreous fluid. Graefes Arch Clin Exp Ophthalmol. 2014; 252: 1235-1243
  209. Ishizuka ET, Kanda A, Kase S, Noda K, Ishida S. Involvement of the receptor-associated prorenin system in the pathogenesis of human conjunctival lymphoma. Invest Ophthalmol Vis Sci. 2014; 56: 74-80
  210. Kase S, Noda M, Yoshikawa H, Yamamoto T, Ishijima K, Ishida S. Oxidative stress in the levator aponeurosis in Asian involutional blepharoptosis. Ophthal Plast Reconstr Surg. 2014; 30: 290-294
  211. Kase S, Ishida S.  Retinal capillary hemangioma in von hippel-lindau disease: current concept, diagnosis and managements. J Transl Med Epidemiol. 2014; 2: 1010
  212. Kase S, Yoshikawa H, Nakajima Y, Noda M, Ishida S. Adenosquamous carcinoma of the conjunctiva.Oncol Lett. 2014; 7: 1941-1943
  213. Kinoshita S, Noda K, Tagawa Y, Inafuku S, Dong Y, Fukuhara J, Dong Z, Ando R, Kanda A, Ishida S. Genistein Attenuates Choroidal Neovascularization. J Nutr Biochem. 2014; 25: 1177-1182
  214. Kinoshita S, Kase S, Ando R, Dong Z, Fukuhara J, Dong Y, Takashina S, Noda K, Noda M, Kanda A, Ishida S. Expression of vascular endothelial growth factor in human ocular adnexal lymphoma. Invest Ophthalmol Vis Sci. 2014; 55: 3461-3467
  215. Lennikov A, Kitaichi N, Noda K, Mizuuchi K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats. Mol Vis. 2014; 20: 171-177
  216. Saito M, Saito W, Hashimoto Y, Yoshizawa C, Shinmei Y, Noda K, Ishida S. Correlation between decreased choroidal blood velocity and the pathogenesis of acute zonal occult outer retinopathy. Clin Experiment Ophthalmol. 2014；42：139-150
  217. Saito M, Saito W, Kanda A, Ohguro H, Ishida S. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase. BMC Ophthalmol. 2014; 14: 5
  218. Takahashi A, Saito W, Hashimoto Y, Saito M, Ishida S. Impaired circulation in the thickened choroid of a patient with serpiginous choroiditis. Ocul Immunol Inflamm. 2014; 22: 409-413
  219. Yoshizawa C, Saito W, Noda K, Ishida S. Pars plana vitrectomy for a patient with macular schisis associated with peripapillary intrachoroidal cavitation. Ophthalmic Surg Lasers Imaging Retina. 2014; 45: 350-353
  220. Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Dong Y, Takashina S, Kanda A, Noda M, Noda K, Ishida S. Expression of alphaB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. Anticancer Res. 2013; 33: 3745-3752
  221. Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis. 2013; 19:536-543
  222. Fukuhara J, Kase S, Ohashi T, Ando R, Dong Z, Noda K, Ohguchi T, Kanda A, Ishida S. Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol. 2013; 139: 381-389
  223. Fukuhara J, Noda K, Murata M, Namba S, Kinoshita S, Dong Z, Ando R, Lennikov A, Kanda A, Ishida S. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2013; 54: 274-279
  224. Hirooka K, Saito W, Noda K, Ishida S. A patient with acute macular neuroretinopathy and central retinal vein occlusion. Clin Ophthalmol. 2013; 7: 1447-1450
  225. Jin XH, Namba K, Saito W, Iwata D, Ishida S. Bacterial endophthalmitis caused by an intraocular cilium in a patient under treatment with infliximab. J Ophthalmic Inflamm and Infect. 2013; 3:50
  226. ●Kanda A, Ishida S. Vitreous renin-angiotensin system is mediated by soluble (pro)renin receptor in diabetic retinopathy: New implication of receptor-associated prorenin system. Twn J Ophthalmol. 2013; 3:51-53
  227. ●Kanda A, Noda K, Saito W, Ishida S. Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol. 2013; 97: 666-668
  228. ●Kanda A, Noda K, Yuki K, Ozawa Y, Furukawa T, Ichihara A, Ishida S. Atp6ap2/(pro)renin receptor interacts with Par3 as a cell polarity determinant required for laminar formation during retinal development in mice. J Neurosci. 2013; 33: 19341-19351
  229. Kase S, Namba K, Kitaichi N, Iwata D, Ohno S, Ishida S. Clinical features of human T lymphotropic virus type-1 associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol. 2013; 57: 379-384
  230. Kase S, Noda M, Ishijima K, Yamamoto T, Hatanaka K, Ishida S. IgG4-related inflammation of the orbit simulating malignant lymphoma. Anticancer Res. 2013; 33: 2779-2783
  231. Kase S, Rao NA, Yoshikawa H, Fukuhara J, Noda K, Kanda A, Ishida S. Expression of vascular endothelial growth factor in eyes with Coats disease. Invest Ophthalmol Vis Sci. 2013; 54: 57-62
  232. Kase S, Yamamoto T, Ishijima K, Noda M, Ishida S. Spontaneous regression of IgG4-related dacryoadenitis. Mod Rheumatol. 2013; 23: 1018-1021
  233. Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Song R, Kang YM, Kang SW, Baek HJ, Kitaichi N, Meguro A, Mizuki N, Namba K, Ishida S, Kim J, Niemczek E, Lee EY, Song YW, Ohno S, Lee EB. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis. 2013; 72: 1510-1516
  234. Lennikov A, Kitaichi N, Kase S, Noda K, Horie Y, Nakai A, Ohno S, Ishida S. Induction of heat shock protein 70 ameliorates ultraviolet-induced photokeratitis in mice. Int J Mol Sci. 2013; 14;2175-2189
  235. Mizuuchi K, Kitaichi N, Namba K, Horie Y, Ishida S, Ohno S. Trabecular meshwork depigmentation in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2013; 57: 245-251
  236. ●Noda K, Ishida S. Role of chronic inflammation in diabetic retinopathy. Inflamm Regen. 2013; 33: 230-237
  237. Ohguchi T, Kojima T, Ibrahim OM, Nagata T, Shimizu T, Shirasawa T, Kawakita T, Satake Y, Tsubota K, Shimazaki J, Ishida S. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (Sod1) knockout mice. Invest Ophthalmol Vis Sci. 2013; 54: 7793-7802
  238. Ozeki N, Shinoda K, Ohde H, Ishida S, Tsubota K. Improvement of visual acuity after transcorneal electrical stimulation in case of Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2013; 251:1867-1870
  239. Saito M, Saito W, Hashimoto Y, Yoshizawa C, Fujiya A, Noda K, Ishida S. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol. 2013; 97: 775-780
  240. Saito W, Kase S, Fujiya A, Dong Z, Noda K, Ishida S. Expression of vascular endothelial growth factor (VEGF) and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Retina. 2013; 33: 1959-1967
  241. Saito W, Kase S, Ohguro H, Ishida S. Autoimmune retinopathy associated with colonic adenoma. Graefes Arch Clin Exp Ophthalmol. 2013; 251: 1447-1449
  242. Takashina S, Saito W, Noda K, Katai M, Ishida S. Membrane tissue on the optic disc may cause macular schisis associated with a glaucomatous optic disc without optic disc pits. Clin Ophthalmol. 2013; 7: 883-887
  243. Terasaki H, Kase S, Shirasawa M, Otsuka H, Sonoda S, Ishida S, Sakamoto T. TNF-α decreases VEGF secretion in highly polarized RPE cells but increases it in non-polarized RPE cells related to crosstalk between JNK and NF-κB pathways. PLoS One. 2013; 8: e69994
  244. Yaguchi S, Ogawa Y, Shimmura S, Kawakita T, Hatou S, Satofuka S, Nakamura S, Imada T, Miyashita H, Yoshida S, Yaguchi T, Ozawa Y, Mori T, Okamoto S, Kawakami Y, Ishida S, Tsubota K. Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease. PLoS One. 2013; 8: e64724
  245. Yamane S, Lee A, Hanaoka N, Gonzalez G, Kaneko H, Ishida S, Kitaichi N, Ohno S, Koyanagi K, Aoki K, Fujimoto T, Yawata N, Watanabe H. Identification of contamination in the American Type Culture Collection stock of human adenovirus type 8 by whole genome sequencing. J Virol. 2013; 87:1285-1286
  246. Yoshikawa N, Noda K, Ozawa Y, Mashima Y, Ishida S. Blockade for vascular adhesion protein-1 suppresses pathological neovascularization in oxygen-induced retinopathy. Acta Ophthalmol. 2013; e409-e410
  247. Yoshikawa N, Noda K, Shinoda H, Uchida A, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type Ⅱ J Diabetes Complications. 2013; 27: 162-166
  248. Yoshizawa C, Saito W, Hirose S, Kitamei H, Noda K, Ishida S. Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Jpn J Ophthalmol. 2013; 57: 68-73
  249. Chin S, Nitta T, Shinmei Y, Aoyagi M, Nitta A, Ohno S, Ishida S, Yoshida K. Reduction of intraocular pressure using a modified 360-degree suture trabeculotomy technique in primary and secondary open-angle glaucoma: A pilot study. J Glaucoma. 2012; 21: 401-407
  250. Dong Z, Kase S, Ando R, Fukuhara J, Saito W, Kanda A, Murata M, Noda K, Ishida S. AlphaB-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy. Retina. 2012; 32: 1190-1196
  251. Fukuhara J, Kase S, Noda K, Kanda A, Murata M, Noda M, Ando R, Dong Z, Ishida S. Immunolocalization of vascular adhesion protein-1 in human conjunctival tumors. Ophthalmic Res. 2012; 48: 33-37
  252. Fukuhara J, Kase S, Noda M, Ishijima K, Yamamoto T, Ishida S. Conjunctival lymphoma arising from reactive lymphoid hyperplasia. World J Surg Oncol. 2012; 10: 194
  253. Hashimoto Y, Kase S, Saito W, Ishida S. Abnormalities of fundus autofluorescence in pigmented paravenous chorioretinal atrophy. Open Ophthalmol J. 2012; 6: 125-128
  254. Hashimoto Y, Saito W, Mori S, Saito M, Ishida S. Increased macular choroidal blood flow velocity during systemic corticosteroid therapy in a patient with acute macular neuroretinopathy. Clin Ophthalmol. 2012; 6: 1645-1649
  255. Hase K, Kase S, Noda M, Ohashi T, Shinkuma S, Ishida S. Ectopic cilia: A histopathologic study. Case Report Dermatol. 2012; 4: 37-40
  256. Horie Y, Meguro A, Kitaichi N, Lee E B, Kanda A, Noda K, Song Y W, Park K S, Namba K, Ota M, Inoko H, Mizuki N, Ishida S, Ohno S. Replication of a microsatellite genome-wide association study of Behcet disease in a Korean population. Rheumatology. 2012; 51: 983-986
  257. Ishijima K, Namba K, Ohno S, Mochizuki K, Ishida S. Intravitreal injection of bevacizumab in a case of occlusive retinal vasculitis accompanied with syphilitic intraocular inflammation. Case Report Ophthalmol. 2012; 3: 434-437
  258. Iwata D, Namba K, Mizuuchi K, Kitaichi N, Kase S, Takemoto Y, Ohno S, Ishida S. Correlation between elevation of serum antinuclear antibody titre and decreased therapeutic efficacy in the treatment of Behçet’s disease with infliximab. Graefes Arch Clin Exp Ophthalmol. 2012; 250: 1081-1087
  259. ●Kanda A, Noda K, Oike Y, Ishida S. Angiopoietin-like protein 2 mediates endotoxin-induced acute inflammation in the eye. Lab Invest. 2012; 92: 1553-1563
  260. ●Kanda A, Noda K, Saito W, Ishida S. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy. Diabetologia. 2012; 55: 3104-3113
  261. Kase S, Meghpara BB, Ishida S, Rao NA. Expression of alphaA-crystallin in the retina of human sympathetic ophthalmia. Mol Med Report. 2012; 5: 395-399
  262. Kase S, Namba K, Jin XH, Kubota K, Ishida S. Spontaneous regression of intraocular lymphoma. Ophthalmology. 2012; 119: 1083-1084
  263. Kitamei H, Namba K, Kitaichi N, Wakayama A, Ohno S, Ishida S. Chickenpox chorioretinitis with retinal exudates and periphlebitis. Case Report Ophthalmol. 2012; 3:180-184
  264. Kurihara T, Ozawa Y, Ishida S, Okano H, Tsubota K. Renin-angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction. Int J Inflam. 2012; 2012: 581695
  265. Lennikov A, Kitaichi N, Fukase R, Murata M, Noda K, Ando R, Ohguchi T, Kawakita T, Ohno S, Ishida S. Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops. Mol Vis. 2012; 18: 455-464
  266. Lennikov A, Kitaichi N, Noda K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Mizutani M, Fujikawa T, Itai A, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012; 18: 2586-2597
  267. Murata M, Noda K, Fukuhara J, Kanda A, Kase S, Saito W, Ozawa Y, Mochizuki S, Kimura S, Mashima Y, Okada Y, Ishida S. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53: 4055-4062
  268. Noda K, Nakao S, Ishida S, Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol. 2012; 2012: 279037
  269. Saito M, Yoshida K, Saito W, Fujiya A, Ohgami K, Kitaichi N, Tsukahara H, Ishida S, Ohno S. Astaxanthin increases choroidal blood flow velocity. Graefes Arch Clin Exp Ophthalmol. 2012; 250: 239-245
  270. Sasaki M, Yuki K, Kurihara T, Miyake S, Noda K, Kobayashi S, Ishida S, Tsubota K, Ozawa Y. Biological role of lutein in the light-induced retinal degeneration. J Nutr Biochem. 2012; 23: 423-429
  271. ●Satofuka S, Kanda A, Ishida S. Receptor-associated prorenin system in the pathogenesis of retinal diseases. Front Biosci. 2012; 4: 1449-1460
  272. Takemoto Y, Namba K, Mizuuchi K, Ohno S, Ishida S. Two cases of subfoveal choroidal neovascularization with tubulointerstitial nephritis and uveitis (TINU) syndrome. Eur J Ophthalmol. 2012; 23: 255-257
  273. Uchida A, Shinoda K, Matsumoto CS, Kawai M, Kawai S, Ohde H, Ozawa Y, Ishida S, Inoue M, Mizota A, Tsubota K. Acute visual field defect following vitrectomy determined to originate from optic nerve by electrophysiological tests. Case Rep Ophthalmol. 2012; 3: 396-405
  274. Yaguchi S, Ogawa Y, Shimmura S, Hatou S, Nakamura S, Inaba T, Imada T, Ozawa Y, Kawakami Y, Ishida S, Tsubota K. Presence and physiological function of Renin-Angiotensin System in mouse lacrimal gland. Invest Ophthalmol Vis Sci. 2012; 53: 5416-5425
  275. Yoshikawa N, Noda K, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization. Mol Vis. 2012; 18: 593-600
  276. Yoshizawa C, Saito W, Kase M, Ishida S. Clinical features of central retinal vein occlusion with inflammatory etiology.Asia Pac J Ophthalmol. 2012; 1: 270-276
  277. Ando R, Kase S, Ohashi T, Dong Z, Fukuhara J, Kanda A, Murata M, Noda K, Kitaichi N, Ishida S. Tissue factor expression in human pterygium. Mol Vis. 2011; 17:63-69
  278. Fukuhara J, Kase S, Ishijima K, Noda M, Ishida S. Conjunctival lymphoproliferative disorder. Ophthalmology. 2011; 118: 423
  279. Fukuhara J, Kase S, Noda M, Ishijima K, Ishida S. Extranodal marginal zone B-cell lymphoma involving superior rectus muscle: A clinicopathological case report. Oncol Lett. 2011; 2: 489-491
  280. Hashimoto A, Hashimoto S, Ando R, Noda K, Ogawa E, Kotani H, Hirose M, Menju T, Morishige M, Manabe T, Toda Y, Ishida S, Sabe H. GEP100-Arf6-AMAP1-Cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis. PLoS ONE. 2011; 6: e23359
  281. Hirasawa M, Noda K, Noda S, Suzuki M, Ozawa Y, Shinoda K, Inoue M, Ogawa Y, Tsubota K, Ishida S. Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization. Mol Vis. 2011; 17: 1222-1230
  282. Horie Y, Saito W, Kitaichi N, Miura T, Ishida S, Ohno S. Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2011; 55: 57-61
  283. Ishijima K, Kase S, Noda M, Ishida S. Intraocular neovascularization associated with choroidal ganglioneuroma in neurofibromatosis type-1. Eur J Ophthalmol. 2011; 21: 837-840
  284. Jin XH, Aoki K, Kitaichi N, Ariga T, Ishida S, Ohno S. Genome variability of human adenovirus type 8 causing epidemic keratoconjunctivitis during 1986-2003 in Japan. Mol Vis. 2011; 17: 3121-3127
  285. Jin XH, Ishii A, Aoki K, Ishida S, Mukasa K, Ohno S. Detection of human adenovirus hexon antigen using carbon nanotube sensors. J Virol Methods. 2011; 171: 405-407
  286. Kaneko H, Aoki K, Ishida S, Ohno S, Kitaichi N, Ishiko H, Fujimoto T, Ikeda Y, Nakamura M, Gonzalez G, Koyanagi KO, Watanabe H, Suzutani T. Recombination analysis of intermediate human adenovirus type 53 in Japan by complete genome sequence. J Gen Virol. 2011; 92: 1251-1259
  287. Kaneko H, Suzutani T, Aoki K, Kitaichi N, Ishida S, Ishiko H, Ohashi T, Okamoto S, Nakagawa H, Hinokuma R, Asato Y, Oniki S, Hashimoto T, Iida T, Ohno S. Epidemiological and virological features of epidemickeratoconjunctivitis due to new human adenovirus type 54 in Japan. Br J Ophthalmol. 2011; 95: 32-36
  288. Kase S, Ishida S, Rao NA. Immunolocalization of advanced glycation end products in human diabetic eyes: an immunohistochemical study. Journal of Diabetes Mellitus (JDM). 2011; 1: 57-62
  289. Kase S, Ishida S, Rao NA. Increased expression of alphaA-crystallin in human diabetic eye. Int J Mol Med. 2011; 28: 505-511
  290. Kase S, Noda M, Ishijima K, Ishida S. Giant conjunctival mucosa-associated lymphoid tissue lymphoma. Arch Ophthalmol. 2011; 129: 1344
  291. Kase S, Yoshida K, Suzuki S, Ohshima KI, Ohno S, Ishida S. Diffuse infiltrating retinoblastoma invading subarachnoid space. Clin Ophthalmol. 2011; 5: 861-863
  292. Kawamura R, Inoue M, Shinoda H, Shinoda K, Itoh Y, Ishida S, Tsubota K. Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide. J Ocul Pharmacol Ther. 2011; 27: 299-304
  293. ●Kubota S, Ozawa Y, Kurihara T, Sasaki M, Yuki K, Miyake S, Noda K, Ishida S, Tsubota K. Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Invest Ophthalmol Vis Sci. 2011; 52: 9142-9148
  294. Kubota M, Shimmura S, Kubota S, Miyashita H, Kato N, Noda K, Ozawa Y, Usui T, Ishida S, Umezawa K, Kurihara T, Tsubota K. Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model. Invest Ophthalmol Vis Sci. 2011; 52: 427-433
  295. Noda M, Noda K, Ideta S, Nakamura Y, Ishida S, Inoue M, Tsubota K. Repair of blowout orbital floor fracture by periosteal suturing. Clin Experiment Ophthalmol , 2011; 39: 364-369
  296. Suzuki M, Ozawa Y, Kubota S, Hirasawa M, Miyake S, Noda K, Tsubota K, Kadonosono K, Ishida S. Neuroprotective response after photodynamic therapy: Role of vascular endothelial growth factor. J Neuroinflamm. 2011; 8: 176
  297. Takahashi M, Kinoshita S, Saito W, Kase M, Ishida S. Choroidal neovascularization in a patient with blunt trauma-caused traumatic retinopathy without choroidal rupture. Graefes Arch Clin Exp Ophthalmol. 2011; 249: 137-140
  298. Tano Y, Ohji M, Iida T, Ishibashi T, Ishida S, Kishi S, Okada AA, Sato Y, Shiraga F, Shiraki K, Terasaki H,Yuzawa M. Long-term efficacy and safety of ranibizumab adinistered pro re nata in Japanese patients with neovascular age-related macular degeneration in the EXTEND-I study. Acta Ophthalmol. 2011; 89: 208-217
  299. Yuki K, Ozawa Y, Yoshida T, Kurihara T, Hirasawa M, Ozeki N, Shiba D, Noda K, Ishida S, Tsubota K. Retinal ganglion cell loss in superoxide dismutase 1-deficiency. Invest Ophthalmol Vis Sci. 2011; 52: 4143-4150
  300. Inoue M, Shinoda K, Matsuda-Yamamitsu T, Sano RY, Ishida S. Combined vitreous and cataract surgeries in highly hyperopic eye. Clin Ophthalmol. 2010; 4: 1003-1005
  301. ＊Ishida S, Koto T, Nagai N, Oike Y. Calcium channel blocker nilvadipine, but not diltiazem, inhibits ocular inflammation in endotoxin-induced uveitis. Jpn J Ophthalmol. 2010; 54: 594-601
  302. Iwata D, Kitaichi N, Ebihara A, Iwabuchi K, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K, Todo S, Ishida S, Onoé K. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B inhibitor dehydroxy methyl epoxyquinomicin in mice. Invest Ophthalmol Vis Sci. 2010; 51: 2077-2084
  303. Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, Namba K, Morimoto J, Ebihara A, Kitamei, H, Yoshida K, Ishida S, Ohno S, Uede T, Onoé K, Iwabuchi K. Prevention of experimental autoimmune uveoretinitis by blockade of Osteopontin with small interfering RNA. Exp Eye Res. 2010; 90: 41-48
  304. Kase S, Ishijima K, Ishida S, Rao NA. Merkel cell carcinoma of the conjunctiva. Ophthalmology. 2010; 117: 637
  305. Kase S, Saito W, Ohno S, Ishida S.Cyclooxygenase-2 expression in human idiopathic epiretinal membrane. Retina. 2010; 30: 719-723
  306. Kitaichi N, Kitamura M, Namba K, Ishida S, Ohno S. Elevation of surfactant protein D, a pulmonary disease biomarker,in the sera of uveitis patients with sarcoidosis. Jpn J Ophthalmol. 2010; 54: 81-84
  307. ●Kubota S, Kurihara T, Ebinuma M, Kubota M, Yuki K, Sasaki M, Noda K, Ozawa Y, Oike Y,Ishida S, Tsubota K.　Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation.　Am J Pathol. 2010; 177: 1725-1731
  308. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, Simon MC, Johnson RS, Suematsu M, Tsubota K, Ishida S, Goda N, Suda T, Okano H. Von Hippel-Lindau protein regulates transition from fetal to adult circulatory system in retina. Development. 2010; 137: 1563-1571
  309. Sasaki M, OzawaY, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K. Neurodegenerative influence of oxidative stressin the retina of diabetic mice.  Diabetologia. 2010; 53: 971-979
  310. Sugisaka E, Shinoda K, Sano RY, Ishida S, Imamura Y, Ozawa Y, Shinoda H, Suzuki K, Tsubota K, Inoue M. Mechanism of visual sensations experienced during pars plana vitrectomy under retrobulbar anesthesia. Ophthalmologica. 2010; 224: 103-108
  311. ●Suzuki M, Noda K, Kubota S, Hirasawa M, Ozawa Y, Tsubota K, Mizuki N, Ishida S. Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis. Mol Vis. 2010; 16: 1382–1388
  312. Tabbara KF, Omar N, Hammouda E, Akanuma M, Ohguchi T, Ariga T, Tagawa Y, Kitaichi N, Ishida S, Aoki K, Ishiko H, Ohno S. Molecular epidemiology of adenoviral keratoconjunctivitis in Saudi Arabia. Mol Vis. 2010; 16: 2132-2136
  313. Tano Y, Ohji M, Iida T, Ishibashi T, Ishida S, Kishi S, Ogura Y, Ohji M, Okada AA, Sato Y, Shiraga F, Shiraki K, Tano Y, Terasaki H, Yagi F, Yoshimura N, Yuzawa M. EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Acta Ophthalmol. 2010; 88: 309-316
  314. ●Tomita Y, Noda K, Shinoda H, Ozawa Y, Tsubota K, Ishida S. Secondary macular hole formation with presumed evulsion of foveal hard exudates in a patient with diabetic retinopathy. Jpn J Ophthalmol. 2010; 54: 366-368
  315. Yuki Y, Inoue M, Shiba D, Kawamura R, Ishida S, Ohtake Y. Selective laser trabeculoplasty for elevated intraocular pressure following subtenon injection of triamcinolone acetonide. Clin Ophthalmol.2010; 4: 247–249
  316. ●Hirasawa M, Noda K, Shinoda H, Ozawa Y, Tsubota K, Ishida S. Case of secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection. Jpn J Ophthalmol. 2009; 53: 279-281
  317. 　Horie Y, Kitaichi N, Katsuyama Y, Yoshida K, Miura T, Ota M, Asukata Y, InokoH, Mizuki N, Ishida S, Ohno S. Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis. 2009; 15: 1115-1119
  318. Ideta S, Noda M, Kawamura R, Shinoda K, Suzuki K, Ishida S, Inoue M. Dehiscence of levator aponeurosis in ptosis after subtenon injection of triamcinolone acetonide. Can J Ophthalmol. 2009; 44: 668-672
  319. Kase S, Saito W, Ohno S, Ishida S. Proliferative diabetic retinopathy with lymphocyte-rich epiretinal membrane associated with poor visual prognosis. Invest Ophthalmol Vis Sci. 2009; 50: 5909-5912
  320. ●Kubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K. Prevention of ocular inflammation in endotoxin-induced uveities with resveratrol via inhibiting oxidative damage and nuclear factor-κB activation. Invest Ophthalmol Vis Sci. 2009; 50: 3512-3519
  321. Kurihara T, Omoto M, Noda K, Ebinuma M, Kubota S, Koizumi H, Yoshida S, Ozawa Y, Shimmura S, Ishida S, Tsubota K. Retinal phototoxicity in a novel murine model of intraocular lens implantation. Mol Vis. 2009; 15: 2751-2761
  322. Kurihara T, Suzuki K, Noda K, Kawamura R, Nagai N, Shinoda H, Shinoda K, Tsubota K, Ishida S, Inoue M. New retractor capable of aspirating fluids during scleral buckling surgery. Retina. 2009; 29: 1542-1544
  323. Michikawa T, Ishida S, Nishiwaki Y, Kikuchi Y, Tsuboi T, Hosoda K, Ishigami A, Iwasawa S, Nakano M, Takebayashi T. Serum antioxidants and age-related macular degeneration among older Japanese. Asia Pac J Clin Nutr. 2009; 18: 1-7
  324. Michikawa T, Nishiwaki Y, Kikuchi Y, Nakano M, Iwasawa S, Asakura K, Milojevic A, Mizutari K, Saito H, Ishida S, Okamura T, Takebayashi T. Gender-specific associations of vision and hearing impairments with adverse health outcomes in older Japanese: a population-based cohort study. BMC Geriatr. 2009; 9: 50
  325. ●Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, Koto T, Kurihara T, Noda K, Ozawa Y, Ishimoto T, Kawakami Y, Tanihara H, Saya H, Ishida S, Tsubota K. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci.2009; 50: 4410-4415
  326. Okunuki Y, Usui Y, Nagai N, Kezuka T, Ishida S, Takeuchi M, Goto H. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan. Invest Ophthalmol Vis Sci. 2009; 50: 2255-2261
  327. Sasaki M, Ozawa Y, Kurihara T, Noda K, Imamura Y, Kobayashi S, Ishida S, Tsubota K. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci. 2009; 50: 1433-1439
  328. ●Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A ,Tsubota K, Itoh H, Oike Y, Ishida S. (Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes. 2009; 58: 1625-1633
  329. Chen CJ, Satofuka S, Inoue M, Ishida S, Shinoda K, Tsubota K. Suprachoroidal hemorrhage caused by breakage of a 25-gauge cannula. Ophthalmic Surg Lasers Imaging. 2008; 39: 323-324
  330. Hashizume K, Hirasawa M, Imamura Y, Noda S, Shimizu T, Kurihara T, Noda K, Shinoda K, Ozawa Y, Ishida S, Miyake Y, Shirasawa T, Tsubota K. Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol. 2008; 172: 1325-1331
  331. Inoue M, Shinoda K, Ishida S. Vitrectomy Combined with glial tissue removal at optic pit in patient with optic disc pit maculopathy. J Med Case Reports. 2008; 2: 103
  332. ●Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Ohno S, Oike Y, Ishida S. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci. 2008; 49: 1679-1685
  333. Izumi K, Kohta T, Kimura Y, Ishida S, Takahashi T, Ishiko A, Kosaki K. Tietz syndrome: unique phenotype specific to mutations of MITF nuclear localization signal. Clin Genet. 2008; 74: 93-95
  334. ●Kurihara T, Ozawa Y, Nagai N, Shinoda K, Noda K, Imamura Y, Tsubota K, Okano H, Oike Y, Ishida S. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes. 2008; 57: 2191-2198
  335. ●Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, Shimmura S, Tsubota K, Amano S, Kawakami Y, Ishida S. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Invest Ophthalmol Vis Sci. 2008; 49: 2172-2177
  336. Ozawa Y, Naka o K, Kurihara T, Shimazaki T, Shimmura S, Ishida S, Yoshimura A, Tsubota K, Okano H. Roles of STAT3/SOCS3 pathway in regulation of the visual function and ubiquitin proteasome-dependent degradation of rhodopsin during retinal inflammation. J Biol Chem. 2008; 283: 24561-24570
  337. ●Satofuka S, Ichihara A, Nagai N, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S. (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Am J Pathol. 2008; 173: 1911-1918
  338. Satofuka S, Imamura Y, Ishida S, Ozawa Y, Tsubota K, Inoue M. Rhegmatogenous retinal detachment associated with primary congenital glaucoma. Int Ophthalmol. 2008; 28: 369-371
  339. ●Satofuka S, Ichihara A, Nagai N, Tsubota K, Itoh H, Ishida S. Pathologic roles of (pro)renin receptor in the eye. Front Biosci. 2008; 13: 3884-3895
  340. Shinoda H, Nakajima T, Shinoda K, Suzuki K, Ishida S, Inoue M. Jamming of 25-gauge instruments in the cannula during vitrectomy for dense vitreous hemorrhage. Acta Ophthalmol. 2008; 86: 160-164
  341. Shinoda H, Shinoda K, Satofuka S, Imamura Y, Ozawa Y, Ishida S, Inoue M. Visual recovery after vitrectomy for macular hole using 25-gauge instruments. Acta Ophthalmol. 2008; 86: 151-155
  342. Usui T, Sugisaki K, Iriyama A, Yokoo S, Yamagami S, Nagai N, Ishida S, Amano S. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2008; 49: 4370-4376
  343. Inoue M, Shinoda K, Shinoda H, Kawamura R, Suzuki K, Ishida S. Two-step oblique incision during 25-gauge vitrectomy reduces incidence of postoperative hypotony. Clin Experiment Ophthalmol. 2007; 35: 693-696
  344. Inoue M, Shinoda K, Shinoda H, Suzuki K, Kawamura R, Ishida S. 25-gauge cannula system with microvitreoretinal blade trocar. Am J Ophthalmol. 2007; 144: 302-304
  345. ●Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Umezawa K, Ohno S, Oike Y, Ishida S. Macular pigment lutein is anti-inflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol. 2007; 27: 2555-2562
  346. ●Izumi-Nagai K, Nagai N, Ozawa Y, Mihara M, Ohsugi Y, Kurihara T, Koto T, Satofuka S, Inoue M, Tsubota K, Okano H, Oike Y, Ishida S. Interleukin-6 receptor-mediated activation of STAT3 promotes choroidal neovascularization. Am J Pathol. 2007; 170: 2149-2158
  347. Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci. 2007; 48: 858-865
  348. Kawamura R, Noda K, Negishi K, Shinoda K, Ishida S, Inoue M, Tsubota K. Intraoperative dehiscence of laser subepithelial keratomileusis (LASEK) flap during retinal detachment surgery. Acta Ophthalmol Scand. 2007; 85: 459
  349. Koto T, Inoue M, Shinoda K, Ishida S, Tsubota K. Residual crystals of triamcinolone acetonide may prevent complete closure of the macular hole. Acta Ophthalmol Scand. 2007; 85: 913-914
  350. ●Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Oike Y, Ishida S. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization. Invest Ophthalmol Vis Sci. 2007; 48: 4328-4334
  351. Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, Tsubota K, Okada Y, Ikeda E. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol. 2007; 170: 1389-1397
  352. ●Mochimaru H, Nagai N, Hasegawa G, Kudo-Saito C, Yaguchi T, Usui Y, Kurihara T, Koto T, Satofuka S, Shinoda H, Ozawa Y, Tsubota K, Kawakami Y, Ishida S. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2. Invest Ophthalmol Vis Sci. 2007; 48: 4795-4801
  353. Nagai N, Ishida S, Shinoda K, Imamura Y, Noda K, Inoue M. Surgical effects and complications of indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole. Acta Ophthalmol Scand. 2007; 85: 883-889
  354. ●Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Yamashiro K, Umezawa K, Ishida S. Suppression of diabetes-induced retinal inflammation by blocking angiotensin II type 1 receptor or its downstream NF-κB pathway. Invest Ophthalmol Vis Sci. 2007; 48: 4342-4350
  355. ●Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: Minimal role of bradykinin. Invest Ophthalmol Vis Sci. 2007; 48: 2321-2326
  356. Ozawa Y, Nakao K, Shimazaki T, Shimmura S, Kurihara T, Ishida S, Yoshimura A, Tsubota K, Okano H. SOCS3 is required to temporally fine-tune photoreceptor cell differentiation. Dev Biol. 2007; 303: 591-600
  357. ●Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota T, Itoh H, Oike Y, Ishida S. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci. 2007; 48: 422-429
  358. Shimoda M, Hashimoto G, Mochizuki S, Ikeda E, Nagai N, Ishida S, Okada Y. Binding of ADAM28 to P-selectin glycoprotein ligand-1 enhances P-selectin-mediated leukocyte adhesion to endothelial cells. J Biol Chem. 2007; 282: 25864-25874
  359. Sugisaka E, Shinoda K, Ishida S, Imamura Y, Ozawa Y, Shinoda H, Suzuki K, Tsubota K, Inoue M. Patients' descriptions of visual sensations during pars plana vitrectomy under retrobulbar anesthesia. Am J Ophthalmol. 2007; 144: 245-251
  360. Kurihara T, Ozawa Y, Shinoda K, Nagai N, Inoue M, Oike Y, Tsubota K, Ishida S, Okano H. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci. 2006; 47: 5545-5552
  361. ●Nagai N, Oike Y, Izumi K, Urano T, Kubota Y, Noda K, Ozawa Y, Inoue M, Tsubota K, Suda T, Ishida S. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization.Arterioscler Thromb Vasc Biol. 2006; 26: 2252-2259
  362. ●Satofuka S, Ichihara A, Nagai N, Yamashiro K, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota T, Suzuki F, Oike Y, Ishida S. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci. 2006; 47: 2686-2692
  363. Sugisaka E, Shinoda K, Ishida S, Imamura Y, Ozawa Y, Nakajima T, Shinoda H, Suzuki K, Kawaguchi N, Inoue M. Visual Sensations during Vitrectomy. Ophthalmology. 2006; 113: 1886
  364. Yamaguchi T, Inoue M, Ishida S, Shinoda K. Detecting vitreomacular adhesions in eyes with asteroid hyalosis with triamcinolone acetonide. Graefes Arch Clin Exp Ophthalmol. 2006; 244: 305-308
  365. Inoue M, Shinoda K, Ishida S, Uchida A, Kurosaka D, Katsura H, Tsubota K. Intraocular lens implantation following atopic cataract surgery decreases incidence of postoperative retinal detachment. Ophthalmology. 2005; 112: 1719-1724
  366. Kurihara T, Noda K, Ishida S, Inoue M. Pars plana vitrectomy with internal limiting membrane removal for macular hole associated with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2005; 243: 724-726
  367. ●Nagai N, Noda K, Urano T, Kubota Y, Shinoda H, Koto T, Shinoda K, Inoue M, Shiomi T, Ikeda E, Tsubota K, Suda T, Oike Y, Ishida S. Selective suppression of pathological, but not physiological, retinal neovascularization by blocking angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2005; 46: 1078-1084
  368. ●Nagai N, Oike Y, Noda K, Urano T, Kubota Y, Ozawa Y, Shinoda H, Koto T, Shinoda K, Inoue M, Tsubota K, Yamashiro K, Suda T, Ishida S. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2005; 46: 2925-2931
  369. Noda K, Ishida S, Shinoda H, Koto T, Aoki T, Tsubota K, Oguchi Y, Okada Y, Ikeda E. Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells. Invest Ophthalmol Vis Sci. 2005; 46: 3817-3824
  370. Satofuka S, Inoue M, Shinoda K, Ishida S, Imamura Y, Ando Y. Adherence of intravitreally injected triamcinolone acetonide to the denuded retinal surface after internal limiting membrane peeling. Retina. 2005; 25: 672-673.
  371. Eshita T, Shinoda K, Kimura I, Kitamura S, Ishida S, Inoue M, Mashima Y, Katsura H, Oguchi Y. Retinal blood flow in the macular area before and after scleral buckling procedures for rhegmatogenous retinal detachment without macular involvement. Jpn J Ophthalmol. 2004; 48: 358-363
  372. Hori K, Ishida S, Inoue M, Shinoda K, Kawashima S, Kitamura S, Oguchi Y. Treatment for cystoid macular edema with oral acetazolamide in a patient with Best vitelliform macular dystrophy. Retina. 2004; 24: 481-482
  373. Inoue M, Noda K, Ishida S, Yamaguchi T, Nagai N, Shinoda K, Shinoda H, Oguchi Y. Successful treatment of subfoveal choroidal neovascularization associated with combined hamartoma of the retina and retinal pigment epithelium. Am J Ophthalmol. 2004; 138: 155-156
  374. Inoue M, Noda K, Nagai N, Imamura Y, Ishida S, Oguchi Y. Intraoperative breakage of a 25-gauge vitreous cutter. Am J Ophthalmol. 2004; 138: 867-869
  375. Inoue M, Shinoda K, Ishida S, Shinoda H, Nagai N, Noda K, Oguchi Y. Treatment of retinal detachment following macular translocation with scleral infolding: Preservation of macular translocation. Retina. 2004; 24: 962-964
  376. Inoue M, Yamazaki K, Shinoda K, Ishida S, Shinoda H, Noda K, Oguchi Y. A clinicopathologic case report on macular hole associated with von Hippel-Lindau disease: a novel ultrastructural finding of wormlike, wavy tangles of filaments. Graefes Arch Clin Exp Ophthalmol. 2004; 242: 881-886
  377. Shinoda K, Ohde H, Ishida S, Inoue M, Oguchi Y, Mashima Y. Novel 473-bps deletion in XLRS1 gene in Japanese family with X-linked juvenile retinoschisis. Graefes Arch Clin Exp Ophthalmol. 2004; 242: 561-565
  378. ＊Usui T,# Ishida S,# Yamashiro K, Kaji Y, Poulaki V, Moore JE, Moore TC, Amano S, Horikawa Y, Dartt D, Golding M, Shima DT, Adamis AP. (# equally contributed) VEGF164(165) as the pathological isoform: Differential leukocyte and endothelial responses through VEGFR-1 and VEGFR-2. Invest Ophthalmol Vis Sci. 2004; 45: 368-374
  379. ＊Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, Ogura Y, Hida T, Oguchi Y, Ambati J, Miller JW, Gragoudas ES, Ng YS, D’Amore PA, Shima DT, Adamis AP. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med. 2003; 198: 483-489
  380. ＊Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci. 2003; 44: 2155-2162
  381. ＊Ishida S, Yamashiro K, Usui T, Kaji Y, Ogura Y, Hida T, Honda Y, Oguchi Y, Adamis AP. Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nat Med. 2003; 9: 781-788
  382. Kaji Y, Amano S, Usui T, Oshika T, Yamashiro K, Ishida S, Suzuki K, Tanaka S, Adamis AP, Nagai R, Horiuchi S. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci. 2003; 44: 521-528
  383. Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2003; 44: 2163-2170
  384. Yamashiro K, Tsujikawa A, Ishida S, Usui T, Kaji Y, Honda Y, Ogura Y, AdamisAP. Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. Am J Pathol. 2003; 163: 253-259
  385. Shinoda K, Ohde H, Inoue R, Ishida S, Mashima Y, Oguchi Y. ON-pathway disturbance in two siblings. Acta Ophthalmol Scand. 2002; 80: 219-223
  386. Eshita T, Ishida S, Shinoda K, Kitamura S, Inoue M, Oguchi Y, Yamazaki K. Indocyanine green can distinguish posterior vitreous cortex from internal limiting membrane during vitrectomy with removal of epiretinal membrane. Retina. 2002; 22: 104-106
  387. Shinoda K, Kimura I, Eshita T, Kitamura S, Inoue M, Ishida S, Katsura H, Mashima Y. Microcirculation in the macular area of eyes with an idiopathic epiretinal membrane. Graefes Arch Clin Exp Ophthalmol. 2001; 239: 941-945
  388. Shinoda K, O'hira A, Ishida S, Hoshide M, Ogawa LS, Ozawa Y, Nagasaki K, Inoue M, Katsura H. Posterior synechia of the iris after combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation. Jpn J Ophthalmol. 2001; 45: 276-280
  389. Ogawa Y, Yamazaki K, Kuwana M, Mashima Y, Nakamura Y, Ishida S, Toda I, Oguchi Y, Tsubota K, Okamoto S, Kawakami Y. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci. 2001; 42: 111-119
  390. Shinoda K, Ohde H, Mashima Y, Inoue R, Ishida S, Inoue M, Kawashima S, Oguchi Y. On- and off-responses of the photopic electroretinograms in X-linked juvenile retinoschisis. Am J Ophthalmol. 2001; 131: 489-494
  391. ＊Ishida S, Shinoda K, Kawashima S, Oguchi Y, Okada Y, Ikeda E. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000; 41: 1649-1656
  392. ＊Ishida S, Yamazaki K, Shinoda K, Kawashima S, Oguchi Y. Macular hole retinal detachment in highly myopic eyes: ultrastructure of surgically removed epiretinal membrane and clinicopathologic correlation. Retina. 2000; 20: 176-183
  393. Mashima Y, Shinoda K, Ishida S, Ozawa Y, Kudoh J, Iwata T, Oguchi Y, Shimizu N. Identification of four novel mutations of the XLRS1 gene in Japanese patients with X-linked juvenile retinoschisis. Hum Mutat. 1999; 13: 338
  394. Shinoda K, Ishida S, Kawashima S, Matsuzaki T, Yamada K, Katsura H. A new method for quantification of metamorphopsia in patients with epiretinal membrane. Jpn J Ophthalmol. 2000; 44: 424-427
  395. Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Matsuzaki T, Takayama M, Shinmura K, Yamada M. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol. 1999; 83: 834-837
  396. Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Uchita M, Matsuzaki T, Takayama M, Shinmura K, Yamada M. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy. Curr Eye Res. 2000; 21: 655-661
  397. Shinoda K, Ishida S, Oguchi Y, Mashima Y. Clinical characteristics of 14 japanese patients with X-linked juvenile retinoschisis associated with XLRS1 mutation. Ophthalmic Genet. 2000; 21: 171-180
  398. Shinoda K, Inoue M, Katsura H, Ishida S. A new technique for separation of posterior vitreous in vitreous surgery. Ophthalmic Surg Lasers. 1999; 30: 588-590
  399. Shinoda K, Mashima Y, Ishida S, Oguchi Y. Severe juvenile retinoschisis associated with a 33-bps deletion in XLRS1 gene. Ophthalmic Genet. 1999; 20: 57-61